We report a unique case of successfully performed intraluminal brachytherapy for low volume urethral mucosal recurrence of transitional cell carcinoma urinary bladder, initially treated by transurethral resection of bladder tumor, followed by radical cystectomy. Since the patient was unwilling to undergo any other operational interventions, intraluminal brachytherapy of urethra was attempted. Fluroscopy guided intraluminal HDR brachytherapy using Lumencath(®) catheter under local anesthesia, and remote afterloading system (Nucletron, an Elekta company, Elekta AB, Stockholm, Sweden) was performed. A fraction dose of 7 Gy in seven weekly fractions was prescribed at 0.5 cm from the single applicator. The result was promising in terms of local control and symptomatic relief. Therefore, intraluminal brachytherapy in low volume superficial local disease in urethra may play a potential role, and should be applied when repeated surgery is not feasible due to technical or medical reasons.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635051 | PMC |
| http://dx.doi.org/10.5114/jcb.2013.34451 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
EMVision: An electromagnetic tracking guidance system for accurate placement of interstitial brachytherapy applicators.
Brachytherapy
November 2024
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905.
Article Synopsis
- The study aimed to create and assess EMVision, a system utilizing electromagnetic tracking technology to enhance the placement of brachytherapy applicators, focusing on procedure quality and efficiency.
- EMVision integrates CT imaging and EMT reference frames for precise needle placement, using an automated system that displays real-time 3D visuals and adjusts for anatomy shifts during the procedure.
- Results showed EMVision achieved high accuracy in needle placement, both in phantom tests and human cadaver evaluations, suggesting its potential to streamline brachytherapy procedures and improve training outcomes.
Commissioning considerations for the Bravos high-dose-rate afterloader: Towards improving treatment delivery accuracy.
Brachytherapy
November 2024
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.
Background And Purpose: The upgrade of major equipment can be disruptive to clinical operations and introduce risk as policy and procedures need to adapt to new technical possibilities and constraints. We describe here the transition from GammaMedPlus-iX to Bravos in a busy brachytherapy clinic, involving four afterloaders across two sites.
Material And Methods: Our clinic employs three high-dose-rate remote afterloaders in four dedicated treatment vaults at the main site and a fourth afterloader at a regional location.
Anesthetic Challenges during Endobronchial Brachytherapy: A Case Report.
Acta Med Philipp
May 2024
Department of Anesthesiology, ManilaMed Medical Center Manila, Manila, Philippines.
Lung cancer is the leading cause of cancer death worldwide. It may present as airway obstruction in a patient with endobronchial masses. Endobronchial brachytherapy (EBBT) has been shown to provide palliative therapy.
View Article and Find Full Text PDFMultimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma.
Best Pract Res Clin Gastroenterol
February 2024
Asian Institute of Gastroenterology, Hyderabad, India. Electronic address:
Cholangiocarcinoma (CCA) are primary malignancies of biliary system and usually unresectable at the time of diagnosis. As a consequence, majority of these cases are candidates for palliative care. With the advances in chemotherapeutic agents and multidisciplinary care, the survival rate has improved in cases with inoperable malignant biliary obstruction.
View Article and Find Full Text PDFThe Best Strategy for the Black Hole Phenomenon between Intravascular Ultrasound and Optical Coherence Tomography.
Diagnostics (Basel)
January 2024
Department of Internal Medicine, Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung 40201, Taiwan.
The black hole (BH) phenomenon is an intraluminal restenotic lesion. It was identified by intravascular ultrasound (IVUS) and optical coherence tomography (OCT) after intracoronary brachytherapy and drug-eluting stent implantation. Despite the similarity in the mode of action of brachytherapy and drug-eluting stent implantation, the BH phenomenon appears to be uncommon after drug-eluting stent implantation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!